Showing results (191-200 of 223) with videos related to
Sort By:
Pageof 23
Hepatology (Baltimore, Md.)|June 28, 2020
Changing Epidemiology of Hepatitis A in China: Evidence From Three National Serological Surveys and the National Notifiable Disease Reporting SystemFuzhen Wang, Xiaojin Sun, Feng Wang, et al.Journal of Hematology & Oncology|October 24, 2012
Bortezomib plus rituximab versus rituximab in patients with high-risk, relapsed, rituximab-naïve or rituximab-sensitive follicular lymphoma: subgroup analysis of a randomized phase 3 trialPier Luigi Zinzani, Nuriet K Khuageva, Huaqing Wang, et al.Plos Medicine|April 5, 2017
Demographic transition and the dynamics of measles in six provinces in China: A modeling studySheng Li, Chao Ma, Lixin Hao, et al.Chinese Journal of Cancer Research = Chung-Kuo Yen Cheng Yen Chiu|January 30, 2023
A multi-center, open-label, randomized, parallel-controlled phase II study comparing pharmacokinetic, pharmacodynamics and safety of ripertamab (SCT400) to rituximab (MabThera®) in patients with CD20-positive B-cell non-Hodgkin lymphomaXiaohong Han, Mingzhi Zhang, Huaqing Wang, et al.China CDC Weekly|May 13, 2024
Thirty Years of Experience of Acute Flaccid Paralysis Surveillance for Polio - China, 1993-2022Hong Yang, Ning Wen, Chunxiang Fan, et al.Nature Communications|December 20, 2022
Chronic exposure to synthetic food colorant Allura Red AC promotes susceptibility to experimental colitis via intestinal serotonin in miceYun Han Kwon, Suhrid Banskota, Huaqing Wang, et al.Vaccine|March 17, 2020
Risk factors for measles virus infection and susceptibility in persons aged 15 years and older in China: A multi-site case-control study, 2012-2013Chao Ma, Lixin Hao, Lance Rodewald, et al.Vaccine|March 26, 2016
Risk factors for measles infection in 0-7 month old children in China after the 2010 nationwide measles campaign: A multi-site case-control study, 2012-2013Chao Ma, Christopher J Gregory, Lixin Hao, et al.Journal for Immunotherapy of Cancer|April 10, 2026
Anti-TIM-3 antibody TQB2618 in combination with penpulimab in relapsed or refractory classic Hodgkin lymphoma previously treated with PD-1/PD-L1 therapy: a multicenter, open-label, single-arm, phase Ib clinical trialHuangming Hong, Zegeng Chen, Jie Cui, et al.Vaccine|February 16, 2016
Risk factors for measles in children aged 8 months-14 years in China after nationwide measles campaign: A multi-site case-control study, 2012-2013Lixin Hao, Chao Ma, Kathleen A Wannemuehler, et al.Pageof 23